RCKT position history
The shares of Rocket Pharmaceuticals (RCKT) that MAVERICK CAPITAL LTD reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 1,660,116 shares, $50M, 0.50% of portfolio
- 2021 Q4: 1,894,966 shares, $41M, 0.47% of portfolio, Add +14.1%
- 2022 Q1: 2,133,166 shares, $34M, 0.61% of portfolio, Add +12.6%
- 2022 Q2: 2,532,366 shares, $35M, 0.86% of portfolio, Add +18.7%
- 2022 Q3: 2,532,366 shares, $40M, 0.91% of portfolio
- 2022 Q4: 6,791,636 shares, $133M, 3.1% of portfolio, Add +168.2%
- 2023 Q1: 4,407,623 shares, $76M, 1.9% of portfolio, Reduce −35.1%
- 2023 Q2: 4,379,970 shares, $87M, 1.9% of portfolio, Reduce −0.6%
- 2023 Q3: 5,629,970 shares, $115M, 2.6% of portfolio, Add +28.5%
- 2023 Q4: 4,034,068 shares, $121M, 2.4% of portfolio, Reduce −28.3%
- 2024 Q1: 3,888,312 shares, $105M, 2.0% of portfolio, Reduce −3.6%
- 2024 Q2: 3,928,312 shares, $85M, 1.6% of portfolio, Add +1.0%
- 2024 Q3: 4,118,672 shares, $76M, 1.5% of portfolio, Add +4.8%
- 2024 Q4: 5,198,900 shares, $65M, 1.2% of portfolio, Add +26.2%
- 2025 Q1: 5,199,218 shares, $35M, 0.61% of portfolio, Add 0.0%
- 2025 Q2: 8,363,813 shares, $20M, 0.31% of portfolio, Add +60.9%
- 2025 Q3: 8,468,344 shares, $28M, 0.37% of portfolio, Add +1.2%
- 2025 Q4: 2,513,110 shares, $8.8M, 0.09% of portfolio, Reduce −70.3%
- 2026 Q1: 3,567,372 shares, $13M, 0.15% of portfolio, Add +42.0%
- 2026 Q2: 3,923,963 shares, $13M, 0.12% of portfolio, Add +10.0%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|